We are a team of cancer survivors who are passionate about advancing healthcare and we dedicate ourselves to creating a healthier community of cancer survivors.
Fewer than 10% of children with relapsed or refractory (r/r) ALL will survive 5 years. This approval in the EU for r/r ALL provides European patients with a much-needed new treatment option.
CAR #TCell Therapy Receives Approval for Use Across European Union in #leukemia and #lymphoma another milestone in the fight against cancer, allowing patients in EU to benefit from these potentially lifesaving therapies https://t.co/8KZSM15eur
6 days to Business of Regenerative Medicine @PennMedicine We're excited about all star line up of speakers. Registration still open but limited #celltherapy#immunotherapy#regenmed https://t.co/LCZe0lavBU
Philadelphia Business Journal published an article about @Fight4Cures and our company The Inspired Heroes. Thank you for helping us raise awareness about the potential of immunotherapy! By @PHLBizJGeorge. https://t.co/wCgzIlbVv9 https://t.co/6SX4sCizhy
Nice feature by @BioWriterChik on last night's @ACGTFoundation panel discussion on CAR #TCell technology https://t.co/8WbaTAOlpP @megtirrell https://t.co/gcdMzHq6ea
Cancer Gene Therapy: The next Chapter- an @ACGTFoundation discussion & reception w some of the world’s foremost experts: @carlhjune Oz Azam #Tmunity George Yancopoulos, André Choulika moderated by @megtirrell https://t.co/bF6Q06466I